Effect of curcumin on hypoxia-inducible factor-1 alpha expression in hepatocellular carcinoma cells HepG2 under hypoxia and its possible mechanism

Wei Hou,Hua Qin,Shuang Liu,Ying Wang,Nan-Zhi Liu,Qiu Zhao,De-An Tian
DOI: https://doi.org/10.11569/wcjd.v16.i21.2349
2008-01-01
World Chinese Journal of Digestology
Abstract:AIM: To study the effect of curcumin on hypoxia-inducible factor-1 alpha (HIF-1α) expression in HepG2 hepatocellular carcinoma cells under hypoxic conditions as well as the possible mechanism. METHODS: HepG2 cells were treated with dif- ferent concentrations (0, 1, 2, 5, 10 μmol/L) of curcumin under hypoxic conditions for 6 h. The protein and mRNA levels of HIF-1α were de-tected by Western blot and reverse transcription- polymerase chain reation (RT-PCR) respectively. Then HepG2 cells were treated with 0, 10 μmol/L curcumin, or 10 μmol/L curcumin plus 10 μmol/L MG-132 under hypoxic conditions for 6 h. The protein levels of HIF-1α and vascular en- dothelial growth factor (VEGF) were detected by Western blot. RESULTS: After HepG2 cells were co-incubated with curcumin (1-10 μmol/L) for 6 h, the protein level of HIF-1α decreased signifi cantly as com- pared with that in the control cells (0 μmol/L curcumin treatment ), in a dose-dependent man- ner (F = 79.81, P < 0.01), but the mRNA level of HIF-1α was not affected by curcumin. In the presence of MG-132, a proteasome inhibitor, the HIF-1α and VEGF protein levels decreased by curcunmin was restored to the level of control cells (F = 68.47, 83.79, both P < 0.01). CONCLUSION: Curcumin suppresses HIF-1α expression at post-transcriptional level in HepG2 cells under hypoxia, probably via proteasome- dependent pathway.
What problem does this paper attempt to address?